ALD Newborn Screening in Denmark: What a Three-Step Study Tested

By Lucas Project Foundation

Read the original study’s PubMed record

For families, a screening result starts a conversation. Behind that result, researchers are working on how laboratories can identify babies who need follow-up more accurately.

A Danish study published October 29, 2026 evaluated a three-step approach: two laboratory measurements of a blood marker, followed by targeted genetic analysis. Researchers looked back at dried blood samples from 61,431 newborns, alongside archived samples from people with ALD and other related disorders.

The authors found the approach feasible in this retrospective study. The first two steps identified 21 of 22 known ALD cases; one female patient’s sample fell below the second-step cutoff. That detail matters when interpreting broad claims about screening accuracy.

What families can take from it

This evaluates a laboratory approach. It does not establish that Denmark has launched routine ALD screening, guarantee every case will be found, or predict a child’s future.

You do not need to interpret laboratory cutoffs yourself. Ask your care team what your baby’s result means and which follow-up tests are needed. Follow the timing your screening team gives you.

Further reading: HRSA’s screening and follow-up information.

Previous
Previous

Nezglyal for cerebral ALD: understanding the EU authorization

Next
Next

Why ALD Newborn-Screening Programs Can Differ